Document:

Supplement,dated January 11, 2006, to Letter Agreement

 Confidential Treatment Requested by Fluidigm Corporation 

Exhibit 10.12A 

 

 

 11 January 2006 
 Mr Gajus Worthington 
 CEO 
 Fluidigm Corporation 
 7100 Shoreline Court 

South San Francisco, CA 94080 
  

			
	Re:	 	Supplement to Letter Dated 7 October 2005 Relating to Application for Incentives under the Research Incentive Scheme for Companies (RISC)

Dear Gajus: 
 Reference is made
to the Singapore Economic Development Board’s (“EDB”) Letter of Offer dated 07 October 2005 (the “ LOF “), executed by EDB and relating to the application by Fluidigm Singapore Pte Ltd
(“ Fluidigm Singapore “) for incentives under the Research Incentive Scheme for Companies (“ RISC “). Fluidigm Singapore is a subsidiary of Fluidigm Corporation, a California corporation (“
Fluidigm Parent “). This letter agreement, referred to as the “ Supplemental Agreement, “ is and shall be construed as supplemental to the LOF and every clause of the LOF shall continue in full force and effect
and be binding on the parties thereto save as expressly amended and supplemented by this Supplemental Agreement. For the avoidance of doubt, except as specifically set forth in this Supplemental Agreement, clause 4 of the LOF shall apply to any
breach of conditions under which the RISC grant was approved. For purposes of this Supplemental Agreement, a “ Business Day “ shall refer to any day that is not a Saturday, Sunday, or statutory holiday in Singapore.
Consistent with the RISC grant, this Supplemental Agreement will be deemed effective as of 1 August 2005. 
 For good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, EDB, Fluidigm Singapore, and Fluidigm Parent agree as follows: 
 1. In addition to and based on the milestones and deliverables identified in Paragraph 2 and Annex 1 of the LOF, Fluidigm Singapore shall be required throughout the project development period,
commencing from 1 January 2006, to furnish to EDB annually, quarterly milestones and deliverables for the forthcoming year in accordance with the relevant milestones and deliverables identified in Paragraph 2 and Annex 1 of the LOF (the
“ New Milestone List “). EDB shall be entitled to accept or reject such milestones and deliverables in accordance with paragraph 5 below. Fluidigm Singapore shall deliver the New Milestone List on or before January 31 of
each year. 
 2. Fluidigm Singapore shall deliver to EDB on a quarterly basis evidence of the
satisfaction of previously identified objective milestones and deliverables (as set forth in a New Milestone List) for the entire prior fiscal period of Fluidigm Parent (the “ Quarterly Update Reports “). Quarterly Update
Report submission shall take place no later than the fifth (5 th ) Business Day after the end of each fiscal quarter and shall include Fluidigm Singapore’s claims 

  

					
	 Economic Development Board

 250 North Bridge Road, #28-00 Raffles City Tower, Singapore 179101. Tel: 65 6832 6832 Fax: 65 6832 6565

www.sedb.com
	  	
 	

 
	
  

  
  

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

 

 

  Page
 2
 
  
 
for the entire prior fiscal quarter. The Quarterly Update Reports must be in sufficient detail to satisfy EDB that the milestones and deliverables identified in the applicable New Milestone List
have been met. Scheduled quarterly update meetings or teleconference calls arranged between Fluidigm Singapore and EDB to review the progress of the development project will be held in advance of Quarterly Update Report submission. 

3. If EDB objects to or otherwise disagrees with the conclusion of Fluidigm Singapore and Fluidigm Parent that
the Quarterly Update Report evidences satisfaction in full of the milestones and deliverables previously identified in the New Milestone List for the period covered by such Quarterly Update Report, then EDB shall deliver a written notice to Fluidigm
Singapore and Fluidigm Parent stating its objections or disagreement (“ Notice of Objection “). In the event that EDB delivers a Notice of Objection, EDB, Fluidigm Singapore, and Fluidigm Parent will act in good faith to
promptly resolve any such objection or disagreement. Fluidigm Singapore and Fluidigm Parent shall deliver to EDB a revised Quarterly Update Report which is satisfactory to EDB on or before the fifteenth (15 th ) calendar day after the end of the fiscal quarter. If EDB is
satisfied with the progress of the milestone completion and project achievements as set out in the Quarterly Update Reports, EDB will qualify in writing the company’s quarterly claims for that quarter and limit its right of recovery set forth
in paragraph 4 of the LOF to [***] of the qualified claim amount for that quarterly fiscal period. 
 4. EDB, Fluidigm
Parent, and Fluidigm Singapore agree that Fluidigm may elect to conduct the audits contemplated pursuant to paragraph 2, subsection (t) of the LOF on a half-yearly (i.e., every six months) rather than on an annual basis. In the event that any
such audit reveals inaccuracies or errors that would have resulted in a recovery pursuant to paragraph 4 of the LOF, EDB may effect such recovery, in all events subject to the [***] limitation set forth in paragraph 3 above, directly from Fluidigm
Singapore or, at EDB’s election, as an off-set against future reimbursements. EDB will fully qualify in writing the company’s quarterly claim only upon the company’s subsequent half-yearly submission of externally audited claims for
the quarterly period(s) concerned and satisfactory verification by EDB. 
 5. On or before the tenth
(10th) Business Day following delivery of the New
Milestone List, EDB shall deliver written notice ( “Notice of Objection on Milestone List “) to Fluidigm Singapore and Fluidigm Parent if EDB objects to or otherwise disagrees with the objective milestones and deliverables
identified in any New Milestone List. In the event that EDB delivers a Notice of Objection on Milestone List within the prescribed period, EDB, Fluidigm Singapore, and Fluidigm Parent will act in good faith to promptly resolve any such objection or
disagreement. Fluidigm Singapore and Fluidigm Parent shall, within ten (10) Business Days of the date of the Notice of Objection on Milestone List, deliver to EDB a New Milestone List which is satisfactory to EDB. 

6. in the event of (i) fraud by Fluidigm Singapore or Fluidigm Parent or (ii) any intentional misrepresentation of a
material fact by Fluidigm Singapore or Fluidigm Parent, in either case relating to Fluidigm Singapore’s performance of the activities contemplated by the development project, then the limitations set forth in this Supplemental Agreement
(including, 

  

					
	 Economic Development Board

 250 North Bridge Road, #28-00 Raffles City Tower, Singapore 179101. Tel: 65 6832 6832 Fax: 65 6832 6565

www.sedb.com
	  	
 	

 
	
  

  
  

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

 

 

  Page
 3
 
  
 
without limitation, paragraph 3 of this Supplemental Agreement) on EDB’s right of recovery under paragraph 4 of the LOF shall not apply and EDB reserves the right to full recovery of any
disbursed grant monies. 
 7. Neither the LOF nor this Supplemental Agreement may be amended or modified, nor may any
provision of the LOF or this Supplemental Agreement be waived, except with the written consent of EDB, Fluidigm Singapore, and Fluidigm Parent or in the case of a waiver, the written consent of the party giving such waiver. Except to the extent the
LOF is supplemented, amended, or superseded pursuant to this Supplemental Agreement, the LOF shall remain in full force and effect in accordance with its terms. 
 Yours Sincerely, 
  

	
	 /s/ Dr Beh Swan Gin
  

 Dr Beh Swan Gin
  Director

	Biomedical Sciences
	 EDB

  

					
	 Economic Development Board

 250 North Bridge Road, #28-00 Raffles City Tower, Singapore 179101. Tel: 65 6832 6832 Fax: 65 6832 6565

www.sedb.com
	  	
 	

 
	
  

  
  

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

 

 

 COY-15-RISC/F269-1 

 S05/1-25730208 
 Chairman 

 Economic Development Board 
  250
North Bridge Road 
  #28-00 Raffles City Tower 
  Singapore 179101 
 Attention: DR BEH SWAN GIN 

ACCEPTANCE OF SUPPLEMENTAL AGREEMENT TO THE LOF DATED 7 OCT 2005 PERTAINING TO RESEARCH INCENTIVE SCHEME FOR COMPANIES 

 

	1	I refer to your LOF dated 7 October 2005 and the Supplemental Agreement to the LOF dated 11 January 2006. 

 

	2	I confirm that my company will be undertaking the development project as submitted to the Board dated 15 June 2005 and subsequent revisions and that we accept the
award of your grant not exceeding S$9,926,000 in aggregate, subject to the terms and conditions set out in the LOF dated 7 October 2005 and the above mentioned Supplemental Agreement to the LOF. 

 

	3	We understand the need for EDB to ensure good governance of public fund and hence will ensure that all claims for reimbursement of project expenditure are true and
correct and all terms and conditions as set out in the LOF dated 7 October 2005 and the above mentioned Supplemental Agreement are complied with. 

  

							
	Signature	 	:	 	 /s/ Gajus Worthington
	 	
		 		 	 Mr Gajus Worthington/ CEO Fluidigm
 Corporation
	 	
				
	Signature	 	:	 	 /s/ Grace Yow
	 	
		 		 	Name:	 	
		 		 	Ms Grace Yow / General Manager	 	
				
	Company Stamp	 	:	 		 	
				
		 		 	  
	 	
		 		 	Fluidigm Singapore Pte Ltd	 	
				
	Date	 	:	 	  
	 	

  

					
	 Economic Development Board

 250 North Bridge Road, #28-00 Raffles City Tower, Singapore 179101. Tel: 65 6832 6832 Fax: 65 6832 6565

www.sedb.com
	  	
 	

 
	
  

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.Amended and Restated Letter Agreement

 Confidential Treatment Requested by Fluidigm Corporation 

 

 Exhibit 10.13 
 COY-15-RISC/F269-2 
  S06/1-39831633 
 27 March 2008 
 Ms Grace Yow 
  General Manager 
  Fluidigm Singapore Pte Ltd 

 Block 1026, #07-3532 
  Tai Seng
Avenue 
  Singapore 534413 
 Dear
Ms Grace Yow, 
 APPLICATION FOR INCENTIVES UNDER THE RESEARCH INCENTIVE SCHEME FOR COMPANIES (RISC) 

This is with reference to your application of 26 March 2006 and subsequent revisions for incentives under the Research Incentive
Scheme for Companies. This letter amends, restates and replaces our original letter agreement dated 12 February 2007 (the “Prior Letter”) and all references in the Prior Letter shall be considered references to this amended and
restated letter. 
 2 We are pleased to inform you that the Economic Development Board (hereinafter called “EDB”) has agreed to
provide a grant not exceeding S$3,715,000 in total to Fluidigm Singapore Pte Ltd (hereinafter called “the Company”) under the RISC for your project on the development of the Fluidigm Instrumentation R&D Project (hereinafter called the
“Development Project”), as described in your application. This grant shall be subject to the following conditions: 
  

	 	    	Project Implementation 

  

	  a)	The Company shall implement the Development Project as follows: 

  

	 	(i)	The Company shall implement the Development Project as indicated in the Company’s application dated 26 March 2006 and subsequent revisions.

  

	 	(ii)	The Company shall manufacture all products developed from the Development Project in Singapore for the lifetime of the products. 

 

	 	(iii)	The Company shall be the legal and economic owner of all intellectual property (IP) arising from the Development Project. 

  
 1 

 

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

  

	 	(iv)	The Company shall engage a Singapore-based IP or legal firm(s) to file, draft and manage all patent applications arising from the Development Project.

  

	 	(v)	The Company shall employ at least 10 new Research Scientists and Engineers (RSEs) in Singapore by 31 May 2009 for the Development Project.

  

	 	(vi)	The Company shall employ at least 12 new RSEs in Singapore by 31 May 2011 for the Development Project. 

 

	 	(vii)	The Company shall incur total annual R&D spending of at least S$6.5 million by 31 May 2009 for the Development Project. 

 

	 	(viii)	The Company shall incur total annual R&D spending of at least S$9 million by 31 May 2011 for the Development Project. 

 

	 	(ix)	The Company shall maintain at least 12 RSEs in total at its R&D Centre in Singapore until 31 May 2013. 

 

	 	(x)	Fluidigm Corporation shall raise a minimum of US $45 million in new funding between 1 Jan 2006 and 31 Dec 2008. 

 

	 	(xi)	The Development Project shall meet the project milestones and deliverables as shown in Annex 1. 

 

	 	b)	The Company shall carry out the entire Development Project in Singapore unless otherwise stated. 

 

	 	    	Supported Period 

  

	 	c)	Only expenses incurred during the qualifying period, which shall be from 1 June 2006 to 31 May 2011, will be supported.

  

	 	    	Grant Support 

  

	 	d)	All manpower, equipment, materials & software, professional services and intellectual property rights supported under this RISC grant shall be used exclusively
for the Development Project and shall follow the administrative guidelines laid out in Annex 2. 

  

	 	e)	The Company shall not sell, lease, dispose or otherwise transfer the equipment & software supported under this RISC grant to another party during the execution
of the Development Project without first obtaining the written approval of EDB, which if so granted, shall be on such terms as EDB deems fit. The Company shall at all times maintain proper records with respect to the assets acquired through the
grant. 

  
 2 

 

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

  

	 	f)	The Company shall not seek or receive funds from any other incentives offered by other agencies of the Government of Singapore for funding of this Development Project.

  

	 	g)	All grant monies received shall be used solely for the implementation of this Development project. 

 

	 	    	Project Management & Co-ordination 

  

	 	h)	The Company shall appoint a person (hereinafter called the “Principal Investigator”) to lead the Development Project. The Principal Investigator shall be
responsible for the proper management, co-ordination and progress of the Development Project, the management of grants disbursed and all other matters pertaining to the Development Project, including the preparation of claims, submission of audited
statements and progress reports. 

  

	 	i)	The Principal Investigator shall be deemed as an agent of the Company throughout the Development Project and EDB shall at all times have access to the Principal
Investigator with regards to all matters pertaining to the Development Project. 

  

	 	j)	The Company shall inform EDB in writing of any change in the Principal Investigator. 

 

	 	    	Other Conditions 

  

	 	k)	The Company shall permit EDB officers to inspect the premises where the development work is carried out, the Company’s accounts on the development expenditures and
the records on the progress of the Development Project. 

  

	 	l)	The Company shall be required to provide, through responses to surveys or any other such studies carried out by EDB, relevant information on the Development Project, as
and when requested by EDB. 

  

	 	m)	If required by EDB, the Company shall submit a report comparing its projections in the application form with the actual realised figures. The template for this report
and the timeline for submission will be provided by EDB. 

 3 In the event the Project is aborted, the Company is to inform EDB in
writing immediately. 
 4 EDB reserves the right to recover from the Company the total amount of grant released to the Company for any breach of
condition under which the RISC grant was approved. 

  
 3 

 

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

 5 The Company shall keep the terms and conditions of this RISC grant confidential. Such information
shall not be released to any external party, the public or the press unless prior written consent from EDB is given. 
 6 EDB reserves the right
to change the terms and conditions of this offer from time to time as may be specified and deemed necessary by EDB. 
 7 If you are prepared to
accept this amended and restated offer of a grant under the conditions stipulated above, please sign below and return it to EDB within 1 month from the date of this letter, failing which this offer shall be deemed to have lapsed .

 8 If you have any queries, please contact Ih-Ming CHAN at 6395 7794. For queries on claims, please call the EDAS hotline at 6832 6416. We
wish you every success in this project. 
  

			
	Yours sincerely	 	
		
	YEOH KEAT CHUAN	 	
	 EXECUTIVE DIRECTOR	 	
	 BIOMEDICAL SCIENCES CLUSTER	 	
		
	Enclosures:	 	
		
	Annex 1 Project Milestones and Deliverables	 	
		
	Annex 2 Administrative Guidelines	 	
		
	Accepted and Agreed	 	
		
	FLUIDIGM CORPORATION	 	
		
	/s/ Gajus
Worthington                            	 	
	Name:  Gajus Worthington	 	
	 Title:  President & CEO	 	

  
 4 

 

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

 Annex 1 
 PROJECT MILESTONES AND DELIVERABLES 
 The Company shall meet the following R&D
milestones: 
  

			
	 Milestones
	  	
    Completion Date    

	 AIX Gen II development
	  	
		
	 [***]
	  	[***]
	 [***]
	  	[***]
	 BioMark II Chip Loader development
	  	
		
	 [***]
	  	[***]
	 [***]
	  	[***]
	 [***]
	  	[***]
	 BioMark II End Point Reader development
	  	
		
	 [***]
	  	[***]
	 [***]
	  	
	 [***]
	  	[***]
	 BioMark Next Generation Instrument Development
	  	
		
	 [***]
	  	[***]
	 [***]
	  	[***]
	 [***]
	  	[***]

  
 5 

 

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

 Annex 2 
 ADMINISTRATIVE GUIDELINES 
  

	1.	The grant shall cover 50% of the actual qualifying manpower costs and 30% of the actual qualifying costs for equipment, materials & software, professional
services and intellectual property rights incurred by the Company on the Development Project during the qualifying period. In the event where qualifying cost items are not used exclusively for the Development Project, the qualifying costs items
shall be suitably pro-rated. The qualifying cost items are listed below, but shall be subject to a total maximum grant of S$3,715,000. Virement from one qualifying cost item to another will not be considered and the grant shall not cover GST
payments. 

  

							
	Category	 	 	  	    Approved Grant (S$)	 
	 	 		  	 	 	 
			
	 Manpower
	 		  	 	2,093,592	  
	 Equipment, Materials and Software
	 		  	 	1,188,672	  
	 Professional services
	 		  	 	433,500	  
	 	 
		 		  			
	 Total
	 		  	 	3,715,764	  
		 		  			
	 	 
			
	 Total Approved Grant

  (Rounded down to nearest thousand dollars)
	 		  	 	3,715,000	  
	 	 

  

	2.	The qualifying cost for equipment (less its residual value, if any) is pro-rated based on the number of months the equipment is used for the project (this refers to the
date of delivery to the end of qualifying period) over the approved useful life of equipment. 

 The qualifying
cost of equipment is based on the actual expenses, residual value, number of months that the equipment is used for the project and approved useful life of equipment. 
 The qualifying cost for intellectual property rights (IPR) is pro-rated based on the project duration over the approved useful life of IPR. 

The qualifying cost of IPR is based on the cost of acquiring IPR, project duration and the approved useful life of IPR. 

 

	3.	Disbursements shall be made on a reimbursement basis upon application by the Company at quarterly intervals. Claims must be submitted using the prescribed forms and
shall be certified by the Company’s Chief Financial Officer and the Principal Investigator. The amount disbursed shall be based on the actual qualifying cost item incurred by the Company on the Development Project during the qualifying period.

 The grant will be disbursed as follows: 

 

	 	(i)	Disbursements of up to a cumulative total 70% of the approved grant amount shall be made upon application by the Company. 

 

	 	(ii)	The remaining 30% of the grant may be released upon application by the Company on completion of the Development Project. 

  
  

 

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 

 Confidential Treatment Requested by Fluidigm Corporation 

 

  

	4.	For all claims (except for the final claim), the first 50% of the amount claimed will be disbursed to the Company upon receipt of claim and the remaining 50% will be
disbursed upon the completion of checks. 

  

	5.	The final claim must be submitted within 6 months with complete documentation from the end of the qualifying period (31 May 2011), failing which any
claim will be disqualified. 

  

	6.	For total approved grant exceeding S$100,000, all claims must be externally audited. The audited statement of accounts shall be submitted on an annual basis, as well as
when the Development Project is completed or terminated. The Company shall make available to its auditor this Letter of Offer and its accompanying annexes. The Company shall ensure that the external auditor forwards a copy of the audited accounts
directly to EDB upon completion of the audit. In the event that the external auditor cannot issue an unqualified report, EDB shall have direct access to the external auditor to gather details with regard to the audit findings.

  

	7.	The Company shall submit progress reports to EDB at half-yearly intervals. The disbursement of any grant shall be subject to the Company achieving the project
milestones as stated in the Offer Letter. The final report is to be submitted upon completion of the project. 

  
 7 

  

	[***]	Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}]]